GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Basic Sciences/Adipose Tissue: Nature Reviews Endocrinology | June 2026

Adipose Tissue: Nature Reviews Endocrinology | June 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

• Adipose tissue is no longer viewed simply as a fat storage organ; it is now recognized as a highly active endocrine and neuro-regulatory organ that coordinates whole-body metabolism. • Adipose tissue communicates through two major pathways: Humoral signaling (hormones, metabolites, lipid mediators, cytokines, extracellular vesicles) Neuronal signaling (sympathetic and sensory nerve networks) • Adipose-derived humoral factors include: Adipokines Lipid mediators Metabolites Chemokines Exosomal microRNAs • These signals regulate insulin...


  • Adipose tissue is no longer viewed simply as a fat storage organ; it is now recognized as a highly active endocrine and neuro-regulatory organ that coordinates whole-body metabolism.
  • Adipose tissue communicates through two major pathways:

Humoral signaling (hormones, metabolites, lipid mediators, cytokines, extracellular vesicles)

Neuronal signaling (sympathetic and sensory nerve networks)

  • Adipose-derived humoral factors include:

Adipokines

Lipid mediators

Metabolites

Chemokines

Exosomal microRNAs

  • These signals regulate insulin sensitivity, glucose metabolism, lipid utilization, inflammation, vascular health, and overall cardiometabolic homeostasis.
  • Sympathetic nerves provide rapid control of adipose tissue function, stimulating:

Lipolysis in white adipose tissue

Thermogenesis in brown adipose tissue

Browning of white adipose tissue

  • Sensory nerve fibers act as metabolic sensors, detecting chemical, thermal, and mechanical signals within adipose tissue and relaying information back to the central nervous system.
  • This bidirectional communication creates a sophisticated feedback system linking adipose tissue to the brain and peripheral organs.
  • Cold exposure activates thermogenic adipose tissue and induces release of specific adipokines and lipid mediators that improve systemic glucose and lipid metabolism.
  • Exercise also modifies adipose signaling networks, contributing to many of the metabolic benefits traditionally attributed solely to skeletal muscle.
  • Obesity disrupts both endocrine and neural communication within adipose tissue, resulting in:

Adipokine dysregulation

Chronic inflammation

Insulin resistance

Adipose neuropathy

  • Similar disturbances are observed in:

Type 2 diabetes

Lipodystrophy

Aging-related metabolic disorders

  • Age-related deterioration of adipose signaling may contribute to declining metabolic flexibility and increased cardiometabolic risk.
  • Emerging technologies are rapidly transforming adipose tissue research, including:

Single-cell sequencing

Multi-omics platforms

Secretome profiling

Organoid models

Optogenetics

Click chemistry

  • These tools are enabling unprecedented characterization of adipose-derived signaling molecules and neural circuits.
  • Future therapeutic opportunities may include:

Synthetic adipokine analogues

Lipid mediator–based therapies

Neural circuit modulation

Precision targeting of adipose communication pathways

  • The review places adipose tissue at the center of modern metabolic medicine, linking obesity, diabetes, cardiovascular disease, aging, and energy homeostasis through integrated endocrine and neural networks.

Bottom line: Adipose tissue functions as a sophisticated humoral–neuronal communication hub that actively regulates systemic metabolism. Understanding and manipulating these signaling networks may open new therapeutic avenues for obesity, diabetes, cardiometabolic disease, and healthy aging.

Related Q&A

ARID1A Loss Drives ICC Development: Hepatology | June 2026

Introduction: Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with poor prognosis and limited treatment options. While ICC has traditionally been considered a malignancy of biliary epithelial cells, increasing evidence suggests that hepatocytes can...

Blocking Succinate–GPR91 Signaling in MASH: Hepatology | April 2026

Introduction: Liver fibrosis is the key determinant of long-term outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Activated hepatic stellate cells (HSCs) drive fibrogenesis, but effective antifibrotic therapies remain unavailable. This study investigated whether blocking the succinate–GPR91...

THRSP–MIF Signaling Drives MASH Progression: Hepatology | April 2026

Introduction: The progression from metabolic dysfunction-associated fatty liver (MAFL) to metabolic dysfunction-associated steatohepatitis (MASH) is driven by complex interactions between hepatocytes and immune cells. This study identifies a novel spatial mechanism in the periportal (PP)...

Butyrate and Butyrate-Producing Bacteria in CKM: Antioxidants | July 2026

Introduction: Cardiovascular–Kidney–Metabolic (CKM) syndrome recognizes the close interaction between obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. This review highlights the emerging role of the gut microbiome, particularly butyrate-producing bacteria, as a central...

CK7, CK20, and CDX2 Refine Prognosis in Small Intestinal Adenocarcinoma: Annals of Oncology | 2026

• Small intestinal adenocarcinoma (SIA) is a rare gastrointestinal cancer with limited disease-specific prognostic biomarkers and generally poor outcomes. • This nationwide Dutch population-based study evaluated whether three routinely available immunohistochemical markers—CK7, CK20, and CDX2—have...

Fatty Liver Drives Hyperglycemia Through Liver–Gut Signaling : Cell Metab | Jun 2026

Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to insulin resistance and type 2 diabetes, with the liver traditionally viewed as a key regulator of blood glucose through hepatic glucose production. However, emerging...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer